FTH
Faeth Therapeutics, Inc.
28.40$
+0.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -70.3% | +1.5% | -1.5% | +3.7% | -0.7% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +17.7% | +9.4% | -6.8% | +1.2% | -3.2% | -17.0% | -32.0% | +0.1% | -14.6% | +729.0% | -48.9% | – | |
| – | – | – | – | – | – | – | -24.7% | -13.4% | +20.6% | +606.3% | -53.3% | – | |
| – | +10.0% | +7.3% | -11.0% | +0.4% | -6.5% | +1.3% | -28.4% | -6.8% | +2.2% | +659.9% | -51.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -6.1% | -9.7% | -14.3% | -12.5% | -19.0% | -23.5% | -23.1% | -40.0% | -50.0% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.